Psoriasis Lesion Improvement at Week 16 Maintained to Week 52 with Bimekizumab

Published Date: 29 Mar 2025

These data highlight the long-term maintenance of bimekizumab responses among individuals with psoriasis, looking at bio-naïve and bio-switched patients.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

2.

Cancer Patients' Depression May Be Helped by Psilocybin.

3.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

4.

Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection

5.

Providing essential cancer care to rural communities


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot